Xian-Janssen And China International Medical Foundation To Start Migraine Care Program
This article was originally published in PharmAsia News
Xian-Janssen and China International Medical Foundation have signed an agreement on "GoldenLink," a joint migraine care program. Headed by an expert panel, it will furnish a broad platform for migraine physicians to provide more proper treatment. With the support of Chinese Medical Association and CIMF, GoldenLink will promote standardization of migraine diagnosis and treatment procedures, improve epidemiology data, train more physicians, as well as establish migraine centers and clinics to service more patients. Xian-Janssen will fund the program fully in 2009. (Click here for more - Chinese Language)
You may also be interested in...
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.